The role of genetics for biomarker development in neurodegeneration

被引：18
|
作者：
Bertram, Lars [1 ]
Hampel, Harald [2 ]
机构：
[1] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Neuropsychiat Genet Grp, D-14195 Berlin, Germany
[2] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany
来源：
PROGRESS IN NEUROBIOLOGY | 2011年 / 95卷 / 04期
关键词：
Neurodegenerative disease genetics; Alzheimer's disease; Parkinson's disease; Frontotemporal dementia; Amyotrophic lateral sclerosis; Genetic association; Genome-wide association study; Genetic profiling; Genomic profiling; Risk prediction; Biomarker; GENOMIC MEDICINE; ASSOCIATION;
D O I：
10.1016/j.pneurobio.2011.09.011
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Research on biomarkers and genetics shares a number of objectives, including the identification of novel disease mechanisms, optimization of therapeutic studies, and improvement of diagnosis and prognosis. The latter is of particular relevance in neurodegenerative diseases where the underlying molecular processes often go on for decades until the first clinical symptoms appear. In this commentary we review the potential contribution that insight gained from genetic research may have on biomarker development in neurodegeneration. We argue that future progress will largely depend on a widespread application of novel high-throughput technologies now becoming available in both fields. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：501 / 504
页数：4
相关论文
共 50 条
  • [41] Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
    Nalivaeva, Natalia N.
    Turner, Anthony J.
    Zhuravin, Igor A.
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [42] Role of Oxidative Damage in Alzheimer's Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
    Buccellato, Francesca Romana
    D'Anca, Marianna
    Fenoglio, Chiara
    Scarpini, Elio
    Galimberti, Daniela
    ANTIOXIDANTS, 2021, 10 (09)
  • [43] Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
    Jack, Clifford R., Jr.
    Wiste, Heather J.
    Weigand, Stephen D.
    Knopman, David S.
    Mielke, Michelle M.
    Vemuri, Prashanthi
    Lowe, Val
    Senjem, Matthew L.
    Gunter, Jeffrey L.
    Reyes, Denise
    Machulda, Mary M.
    Roberts, Rosebud
    Petersen, Ronald C.
    BRAIN, 2015, 138 : 3747 - 3759
  • [44] Genetics of multiple sclerosis: Determinants of autoimmunity and neurodegeneration
    Kalam, B
    Albert, RH
    Leist, TP
    AUTOIMMUNITY, 2002, 35 (04) : 225 - 234
  • [45] Converging pathways in neurodegeneration, from genetics to mechanisms
    Li Gan
    Mark R. Cookson
    Leonard Petrucelli
    Albert R. La Spada
    Nature Neuroscience, 2018, 21 : 1300 - 1309
  • [46] Converging pathways in neurodegeneration, from genetics to mechanisms
    Ga, Li
    Cookson, Mark R.
    Petrucelli, Leonard
    La Spade, Albert R.
    NATURE NEUROSCIENCE, 2018, 21 (10) : 1300 - 1309
  • [47] NfL as a biomarker for neurodegeneration and survival in Parkinson disease
    Backstrom, David
    Linder, Jan
    Mo, Susanna Jakobson
    Riklund, Katrine
    Zetterberg, Henrik
    Blennow, Kaj
    Forsgren, Lars
    Lenfeldt, Niklas
    NEUROLOGY, 2020, 95 (07) : E827 - E838
  • [48] Increased Brain Volume A Novel Biomarker of Neurodegeneration?
    DiFrancesco, Jacopo C.
    Stanzani, Lorenzo
    NEUROLOGY, 2022, 98 (16) : 649 - 650
  • [49] Decreased glutamine and glutamate: an early biomarker of neurodegeneration
    Zeydan, Burcu
    Kantarci, Kejal
    INTERNATIONAL PSYCHOGERIATRICS, 2021, 33 (01) : 1 - 2
  • [50] Neurodegeneration in Alzheimer's disease: A new biomarker
    不详
    NEUROSCIENTIST, 2023, 29 (05): : 514 - 514
12345